These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23245648)

  • 21. Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification.
    Stachon AC; Baskin B; Smith AC; Shugar A; Cytrynbaum C; Fishman L; Mendoza-Londono R; Klatt R; Teebi A; Ray PN; Weksberg R
    Am J Med Genet A; 2007 Dec; 143A(24):2924-30. PubMed ID: 18000985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome.
    Dantas AG; Santoro ML; Nunes N; de Mello CB; Pimenta LSE; Meloni VA; Soares DCQ; Belangero SN; Carvalheira G; Kim CA; Melaragno MI
    Hum Genet; 2019 Jan; 138(1):93-103. PubMed ID: 30627818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical nested 22q11.2 duplications between LCR22B and LCR22D are associated with neurodevelopmental phenotypes including autism spectrum disorder with incomplete penetrance.
    Woodward KJ; Stampalia J; Vanyai H; Rijhumal H; Potts K; Taylor F; Peverall J; Grumball T; Sivamoorthy S; Alinejad-Rokny H; Wray J; Whitehouse A; Nagarajan L; Scurlock J; Afchani S; Edwards M; Murch A; Beilby J; Baynam G; Kiraly-Borri C; McKenzie F; Heng JIT
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00507. PubMed ID: 30614210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unusual combination of an atypical maternally inherited novel 0.3 Mb deletion in Williams-Beuren region and a de novo 22q11.21 microduplication in an infant with supravalvular aortic stenosis.
    Evangelidou P; Kousoulidou L; Salameh N; Alexandrou A; Papaevripidou I; Alexandrou IM; Ketoni A; Ioannidou C; Christophidou-Anastasiadou V; Tanteles GA; Sismani C
    Eur J Med Genet; 2020 Dec; 63(12):104084. PubMed ID: 33045407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital diaphragmatic hernia in 22q11.2 deletion syndrome.
    Unolt M; DiCairano L; Schlechtweg K; Barry J; Howell L; Kasperski S; Nance M; Adzick NS; Zackai EH; McDonald-McGinn DM
    Am J Med Genet A; 2017 Jan; 173(1):135-142. PubMed ID: 27682988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH.
    Bittel DC; Yu S; Newkirk H; Kibiryeva N; Holt A; Butler MG; Cooley LD
    Cytogenet Genome Res; 2009; 124(2):113-20. PubMed ID: 19420922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.
    Monteiro FP; Vieira TP; Sgardioli IC; Molck MC; Damiano AP; Souza J; Monlleó IL; Fontes MI; Fett-Conte AC; Félix TM; Leal GF; Ribeiro EM; Banzato CE; Dantas Cde R; Lopes-Cendes I; Gil-da-Silva-Lopes VL
    Eur J Pediatr; 2013 Jul; 172(7):927-45. PubMed ID: 23440478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central 22q11.2 deletions.
    Rump P; de Leeuw N; van Essen AJ; Verschuuren-Bemelmans CC; Veenstra-Knol HE; Swinkels ME; Oostdijk W; Ruivenkamp C; Reardon W; de Munnik S; Ruiter M; Frumkin A; Lev D; Evers C; Sikkema-Raddatz B; Dijkhuizen T; van Ravenswaaij-Arts CM
    Am J Med Genet A; 2014 Nov; 164A(11):2707-23. PubMed ID: 25123976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distal 22q11.2 microduplication combined with typical 22q11.2 proximal deletion: a case report.
    Molck MC; Vieira TP; Simioni M; Sgardioli IC; dos Santos AP; Xavier AC; Gil-da-Silva-Lopes VL
    Am J Med Genet A; 2015 Jan; 167A(1):215-20. PubMed ID: 25358462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed analysis of 22q11.2 with a high density MLPA probe set.
    Jalali GR; Vorstman JA; Errami A; Vijzelaar R; Biegel J; Shaikh T; Emanuel BS
    Hum Mutat; 2008 Mar; 29(3):433-40. PubMed ID: 18033723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2.
    Rauch A; Zink S; Zweier C; Thiel CT; Koch A; Rauch R; Lascorz J; Hüffmeier U; Weyand M; Singer H; Hofbeck M
    J Med Genet; 2005 Nov; 42(11):871-6. PubMed ID: 15831592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristic face: a key indicator for direct diagnosis of 22q11.2 deletions in Chinese velocardiofacial syndrome patients.
    Wu D; Chen Y; Xu C; Wang K; Wang H; Zheng F; Ma D; Wang G
    PLoS One; 2013; 8(1):e54404. PubMed ID: 23342150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
    Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
    Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression.
    Campbell IM; Crowley TB; Jobaliya C; Bailey A; McGinn DE; Gaiser K; Bassett A; Gur RE; Morrow B; Emanuel BS; Franco AT; French D; Zackai EH; McDonald-McGinn DM; Lambert MP
    Clin Genet; 2023 Jan; 103(1):109-113. PubMed ID: 36075864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia.
    Ogata T; Niihori T; Tanaka N; Kawai M; Nagashima T; Funayama R; Nakayama K; Nakashima S; Kato F; Fukami M; Aoki Y; Matsubara Y
    PLoS One; 2014; 9(3):e91598. PubMed ID: 24637876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.
    Zafarullah M; Angkustsiri K; Quach A; Yeo S; Durbin-Johnson BP; Bowling H; Tassone F
    Metabolomics; 2024 Feb; 20(2):31. PubMed ID: 38418685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome.
    de la Morena MT; Eitson JL; Dozmorov IM; Belkaya S; Hoover AR; Anguiano E; Pascual MV; van Oers NSC
    Clin Immunol; 2013 Apr; 147(1):11-22. PubMed ID: 23454892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.
    Gudbrandsen M; Bletsch A; Mann C; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
    Mol Autism; 2020 Jun; 11(1):46. PubMed ID: 32513259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.